# Trade Mark Journal No.2026/010 6 March 2026

## WO0000001889892 (5,42)

Office of origin: United States of America

Date of International Registration:11 September 2025
Date of designation in the UK: 11 September 2025

International priority date claimed: 17 March 2025 (United States of America) (99088465)

Class 5
  Pharmaceuticals; pharmaceutical preparations, namely, pharmaceutical preparations intended to treat prevalent diseases in humans, namely, cardiometabolic diseases, cardiovascular diseases, hypertension, and obesity.
Class 42
  Scientific research; scientific research in the fields of pharmaceuticals and medicine; chemical and medical laboratories.

Corsera LLC

Representative: David A. Cole Cadwalader, Wickersham & Taft LLP, 200 Liberty Street, New York NY 10281, UNITED STATES OF AMERICA